Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Medical and Public Health School of Bahia, Salvador, Brazil lccorreia@terra.com.br.
Luis C L
LC
Correia
Federal University of Bahia, Salvador, Brazil.
Adriana
A
Latado
University of Ulm, Ulm, Germany.
Franz
F
Porzsolt
D002319:Cardiovascular System; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D052216:Glucagon-Like Peptide 1 / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000069450:Liraglutide; D016896:Treatment Outcome
D007004:Hypoglycemic Agents; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1